A re-usable, locally manufactured, half-face respirator provides better protection than fitted disposable N95 masks

Author:

Mbadjeu Hondjeu Arnaud Romeo,Ng William C.K.,Anwari Vahid,Kazlovich Kate,Xiao Maggie Z.X.,Rozenberg Dmitry,Zalewski Alan,Afenu Edem,Hiansen Joshua Qua,Mashari Azad

Abstract

BACKGROUND The coronavirus disease 2019 pandemic has led to persistent shortages of respiratory protective equipment in many jurisdictions. Re-usable industrial respirators have been proposed and deployed as an alternative, but also face severe supply limitations. Numerous respirator designs have been proposed since the start of the current pandemic, but few have been systematically tested on healthcare workers (HCWs). OBJECTIVE In this paper, we describe a locally manufactured respirator named ‘Duo’ that includes separate, valved, inspiratory and expiratory pathways and accommodates up to two filters. Duo was compared with the disposable commercial N95 in a cohort of 41 HCWs using standardised quantitative fit-testing. DESIGN A prospective observational cross-sectional study. SETTING Conducted between May and June 2020 among HCWs at Toronto General Hospital. PARTICIPANTS Forty-one HCWs of both sexes working at Toronto General Hospital. MAIN OUTCOME MEASURES Quantitative fit-testing involving seven tests as prescribed by Canadian standard CSA Z94.4-18. We measured the median overall fit-factors; the individual manoeuvre fit-factors and pass rate. RESULTS The median [IQR] overall fit-factors were 2947 [2228 to 4405] and 77.2 [51.9 to 152.1] for the Duo and disposable N95 respirators respectively (P < 0.0001). The overall pass rate of quantitative fit-testing fitted disposable N95 was 58.5% (24/41), and 100% for the Duo. CONCLUSIONS A re-usable, locally manufactured, half-face respirator performs better than fitted disposable N95 masks as assessed by quantitative fit-testing. This can help address the global supply disruption for a better response to future pandemics. The device requires further modification and testing to optimise exhalation flow resistance, and full conformance with technical standards is required for regulatory approval.

Publisher

Ovid Technologies (Wolters Kluwer Health)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3